PAVmed (PAVM) News Today $1.03 +0.01 (+0.98%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Lucid Diagnostics Submits Clinical Evidence Package to MolDX Seeking Medicare Coverage for EsoGuard® Esophageal DNA TestNovember 20 at 7:56 AM | prnewswire.comLucid Diagnostics to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumNovember 18 at 8:15 AM | prnewswire.comPAVmed Inc. Announces Business Update and Third Quarter 2024 Financial ResultsNovember 18 at 4:11 AM | americanbankingnews.comPAVmed Third Quarter 2024 Earnings: Misses ExpectationsNovember 17, 2024 | finance.yahoo.comPAVmed Positioned for Growth Despite Q3 Revenue Miss: Buy Rating Affirmed by Anthony VendettiNovember 16, 2024 | markets.businessinsider.comPA Vmed Reports Q3 Gains and Strategic AdvancesNovember 15, 2024 | markets.businessinsider.comQ3 2024 PAVmed Inc Earnings CallNovember 15, 2024 | finance.yahoo.comPAVmed Inc (PAVM) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic RestructuringNovember 15, 2024 | finance.yahoo.comPAVmed Inc. (PAVM) Q3 2024 Earnings Call TranscriptNovember 14, 2024 | seekingalpha.comPAVmed Q3 2024 Earnings PreviewNovember 13, 2024 | msn.comLucid Diagnostics Provides Business Update and Third Quarter 2024 Financial ResultsNovember 13, 2024 | prnewswire.comPAVmed's Earnings: A PreviewNovember 12, 2024 | benzinga.comHold Rating Amidst Uncertainty and Transitional Challenges in Q3 2024November 11, 2024 | markets.businessinsider.comIcecure Medical’s ProSense System Gains Favorable FDA Panel Recommendation and Strong Financial Position Supports Buy RatingNovember 9, 2024 | markets.businessinsider.comLucid Diagnostics' ESOGUARD BE-1 Prospective Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing Accepted for Peer-Reviewed PublicationNovember 7, 2024 | prnewswire.comLucid Diagnostics Expands Direct Contracting Initiative with Multiple Programs Focused on Near-Term Revenue DriversNovember 5, 2024 | prnewswire.comLucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 13, 2024October 30, 2024 | prnewswire.comBarfresh Food Group: Strong Growth Prospects and Strategic Initiatives Justify Buy RatingOctober 26, 2024 | markets.businessinsider.comLucid Diagnostics Receives Notice of Allowance for Key Patent Underlying Its EsoGuard Esophageal DNA TestOctober 15, 2024 | prnewswire.comPAVmed Subsidiary Veris Health Granted $1.8 Mln NIH Funding To Enhance Cancer CareOctober 10, 2024 | markets.businessinsider.comPAVmed Subsidiary, Veris Health, Awarded $1.8 Million NIH Grant to Enhance Cancer CareOctober 10, 2024 | prnewswire.comLucid Diagnostics to Participate in the 2024 Maxim Healthcare Virtual SummitOctober 9, 2024 | prnewswire.comLucid Diagnostics to Join Global Medtech Leaders at The MedTech Conference 2024October 8, 2024 | prnewswire.comPAVmed (NASDAQ:PAVM) Stock Quotes, Forecast and News SummaryOctober 7, 2024 | benzinga.comOptimistic Buy Rating for PAVmed Amid Strategic Positioning and Promising Financial OutlookSeptember 26, 2024 | markets.businessinsider.comAmerican Foregut Society's 2024 Annual Meeting to Highlight Lucid Diagnostics' EsoGuard Esophageal Precancer TestSeptember 24, 2024 | prnewswire.comPAVmed moves to deconsolidate Lucid DiagnosticsSeptember 18, 2024 | investing.comPAVmed Announces Efforts to Regain Compliance with Nasdaq Listing RequirementsSeptember 16, 2024 | prnewswire.comPAVmed Inc. (PAVM) interactive stock chart – Yahoo FinanceSeptember 12, 2024 | nz.finance.yahoo.comPAVmed Inc. (PAVM) Interactive Stock Chart - Yahoo FinanceSeptember 11, 2024 | ca.finance.yahoo.comLucid Diagnostics to Host Symposium on Non-Endoscopic Esophageal Precancer Screening at the 20th International Society for Diseases of the Esophagus (ISDE) World CongressSeptember 10, 2024 | prnewswire.comLucid Diagnostics Signs Memorandum of Understanding with Front Line Mobile HealthSeptember 3, 2024 | prnewswire.comLucid Diagnostics Announces Publication of Analytical Validation Study of EsoGuard® for Early Detection of Esophageal Precancer and CancerAugust 20, 2024 | prnewswire.comPAVmed Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues LagAugust 15, 2024 | finance.yahoo.comTalks continue over train drivers’ pay disputeAugust 14, 2024 | msn.comLucid Diagnostics Inc. (NASDAQ:LUCD) Q2 2024 Earnings Call TranscriptAugust 13, 2024 | msn.comPAVmed Provides Business Update and Second Quarter 2024 Financial ResultsAugust 13, 2024 | finance.yahoo.comThe American Foregut Society Formally Requests Medical Policy Coverage of EsoGuard® to Enhance Early Detection of Esophageal CancerAugust 13, 2024 | prnewswire.comHere's what Wall Street expects from PAVmed's earnings reportAugust 12, 2024 | markets.businessinsider.comPAVmed Q2 2024 Earnings PreviewAugust 12, 2024 | msn.comLucid Diagnostics Holds First Major Directly-Contracted EsoGuard® #CheckYourFoodTube Precancer Testing EventAugust 8, 2024 | prnewswire.comLucid Diagnostics Announces Positive Data from ENVET-BE Clinical Utility Study of EsoGuard® Esophageal Precancer TestingAugust 6, 2024 | prnewswire.comLucid Diagnostics to Participate in Upcoming Investor ConferencesAugust 5, 2024 | prnewswire.comLucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 12, 2024July 29, 2024 | prnewswire.comLucid Diagnostics Announces Record Quarterly EsoGuard® Test VolumeJuly 23, 2024 | prnewswire.comLucid Diagnostics Launches New Corporate WebsiteJuly 11, 2024 | prnewswire.comLucid Diagnostics Announces Positive Data from its ESOGUARD BE-1 Prospective, International, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening PopulationJuly 2, 2024 | prnewswire.comPAVmed Subsidiary, Veris Health, Announces Launch of Pilot Program with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research InstituteJune 13, 2024 | prnewswire.com4,000th Firefighter Undergoes Lucid Diagnostics' EsoGuard® Esophageal Precancer TestingJune 12, 2024 | prnewswire.comPAVmed Inc.: PAVmed Provides Business Update and First Quarter 2024 Financial ResultsMay 18, 2024 | finanznachrichten.de Get PAVmed News Delivered to You Automatically Sign up to receive the latest news and ratings for PAVM and its competitors with MarketBeat's FREE daily newsletter. Email Address Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development… YES, I WANT THE #1 CRYPTO NOW PAVM Media Mentions By Week PAVM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PAVM News Sentiment▼0.270.46▲Average Medical News Sentiment PAVM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PAVM Articles This Week▼91▲PAVM Articles Average Week Get PAVmed News Delivered to You Automatically Sign up to receive the latest news and ratings for PAVM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Envoy Medical News Today iCAD News Today Outset Medical News Today Beyond Air News Today Precision Optics News Today Co-Diagnostics News Today BioSig Technologies News Today SurgePays News Today IRIDEX News Today Allurion Technologies News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PAVM) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PAVmed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PAVmed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
